XML 25 R14.htm IDEA: XBRL DOCUMENT
v3.25.3

BALANCE SHEET COMPONENTS | 9 Months Ended
--- | ---
Sep. 30, 2025
Balance Sheet Components [Abstract] |
BALANCE SHEET COMPONENTS | BALANCE SHEET COMPONENTS The following tables present financial information of certain condensed consolidated balance sheet components:
| As of
Accounts receivable, net | September 30, 2025 |  | December 31, 2024
(in thousands) |  |  |
Trade accounts receivable, gross | $ | 21,785 |  |  | $ | 24,099 |
Allowance for credit losses | (5,503) |  |  | (3,787) |
Total accounts receivable, net | $ | 16,282 |  |  | $ | 20,312 |
| As of
Accrued liabilities | September 30, 2025 |  | December 31, 2024
(in thousands) |  |  |
Accrued compensation expenses | $ | 31,171 |  |  | $ | 34,530 |
Accrued clinical studies and research and development expenses | 15,966 |  |  | 13,027 |
Accrued legal and professional service expenses | 4,304 |  |  | 2,966 |
Accrued other expenses | 6,635 |  |  | 6,718 |
Total accrued liabilities | $ | 58,076 |  |  | $ | 57,241 |

X
- Definition Balance Sheet Components + References No definition available. + Details
Name: | gral_BalanceSheetComponentsAbstract
Namespace Prefix: | gral_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/210/tableOfContent + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration